サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1622934

3D細胞培養の世界市場規模：タイプ別、用途別、エンドユーザー別、地域別、範囲および予測

Global 3D Cell Culture Market Size By Type, By Application, By End Users, By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
3D細胞培養の世界市場規模：タイプ別、用途別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年07月26日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

3D細胞培養の市場規模と予測

3D細胞培養の市場規模は、2022年に18億8,000万米ドルと評価され、2023年から2030年までのCAGRは10.87%で、2030年には43億米ドルに達すると予測されています。このセグメントにおける技術の進歩、動物実験に代わる開発への重点の高まり、慢性疾患の罹患率の上昇、新製品の発売が、予測数年間にわたり3D細胞培養市場を牽引すると予想されます。3D細胞培養の世界市場レポートは、同市場の総合的な評価を提供します。主要セグメント、動向、市場促進要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の3D細胞培養市場の定義

3D細胞培養は人工的に作られた環境です。3D細胞培養環境は、生物学的細胞がその周囲の環境と3次元的に相互作用することを可能にします。細胞の特性や挙動において、3D細胞培養で培養された細胞は、生体内で見られる細胞と同様の特性を示します。in vivoの条件下で、この技術は細胞を自然な環境で増殖させることができます。2D環境とは対照的に、3D細胞培養では、人工的に作られた環境の中で細胞をあらゆる方向に成長させることができます。

生物学的細胞は、この環境の中で3次元的に自由に成長し、周囲と相互作用することができます。バイオリアクターや小型カプセルは、このような三次元環境で細胞を増殖させるために頻繁に使用されます。三次元細胞培養は、三次元の周囲環境に反応することによって、通常の細胞から分化・遊走します。細胞の有用性が高まることで、組織の成熟や組織化を助ける。この方法は、製薬会社やバイオテクノロジー企業、学術機関や研究所で一般的に使用されています。

3D培養は、臓器の正常な形態や微細構造を正確に再現できるため、生体内モデル系を必要とする研究において、身体組織や臓器に対する異物の影響を調べるためによく使用されます。さらに、3次元器官型構造を作製するために使用されるバイオミメティック組織構築により、多くの研究機関が3D細胞培養技術を採用しています。さらに、COVID-19、がん、その他の臨床疾患を治療するための従来の方法に対する新しいアプローチとして、3D組織工学モデルの利用が登場しています。

世界の3D細胞培養市場概要

肺がんや皮膚がんなどの腫瘍性疾患に対する一般市民の意識の高まりや、高い強度や低価格といった3D細胞培養の魅力的な利点は、3D細胞培養市場の拡大を促進すると予想される要因の一つです。さらに、医薬品開発における3D細胞培養の利用の高まりや、がん研究や先端技術、新製品発売に対する政府の積極的な財政支援も、3D細胞培養市場を推進すると予想されています。さらに、動物実験に代わる代替法の開発が重視されるようになり、市場認知度が高まっていることも、市場を牽引すると予想されます。慢性疾患の罹患率の増加だけでなく、調査のための資金調達が可能であることが、予測期間中の市場成長を促進すると予測されます。

さらに、創薬、技術革新、スクリーニングのための研究開発努力や、がん研究における3D細胞培養の使用に対する嗜好が、市場成長を促進すると予想されます。同様に、臓器移植需要の増加が3D細胞培養市場の成長を促進すると予測されています。低成長因子の足場上で培養された細胞は、ヒトに移植することができないです。このため、天然ECMの機能性と生物学的・材料的特性を指定できる能力の両方を提供する材料の必要性が強調されています。このような合成ペプチドを含む合成材料で作られた足場は、この障害に対処することが期待されているが、一貫性の欠如が、開始されるまでの間、市場の大きな問題であり続けています。

さらに、過剰な技術コストと熟練した専門家の不足も市場成長の妨げになると予想されます。さらに、COVID-19の流行により、3D細胞培養は、3D細胞培養コンポーネントの需要と入手可能性のバランスをとる上で、深刻な新たな困難に直面しています。神経筋疾患における先進的な治療や診断などの発明の増加は、分析期間中に世界の3D細胞培養市場に豊富な成長機会を提供すると予想されます。さらに、脊髄運動回路全体を再現するための3D細胞培養の進歩が市場を成長させると予想されます。COVID-19に対する新規治療法を開発するための科学研究の増加は、市場成長の大きな機会を示しています。

市場の魅力

提供される市場の魅力のイメージは、さらに世界の3D細胞培養市場で主にリードしている地域についての情報を得るのに役立ちます。我々は、指定された地域における業界の成長を促進する原因となっている主要な影響要因をカバーしています。

ポーターのファイブフォース

この画像は、競合他社の行動と各業界におけるプレーヤーの戦略的ポジショニングを理解するための青写真を提供するポーターのファイブフォースフレームワークに関する情報を得るのに役立ちます。ポーターのファイブフォースモデルは、世界の3D細胞培養市場の競合情勢を評価し、特定分野の魅力を測定し、投資の可能性を評価するために使用することができます。

目次

第1章 世界の3D細胞培養市場：イントロダクション

  • 市場概要
  • 調査範囲
  • 調査スケジュール
  • 前提条件
  • 制限事項

第2章 エグゼクティブサマリー

  • エコロジーマッピング
  • 市場の魅力分析
  • 絶対的収益機会
  • 地理的洞察
  • 将来の市場機会
  • 世界市場分割

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • 2次調査
  • 1次調査
  • 専門家のアドバイス
  • 品質チェック
  • 最終レビュー
  • データの三角測量
  • ボトムアップ・アプローチ
  • トップダウン・アプローチ
  • 調査の流れ
  • データソース

第4章 世界の3D細胞培養市場の展望

  • 概要
  • 市場の進化
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 価格分析

第5章 3D細胞培養の世界市場：タイプ別

  • 概要
  • 3Dバイオリアクター
  • 足場ベースプラットフォーム
  • 足場フリープラットフォーム
  • その他

第6章 3D細胞培養の世界市場：用途別

  • 概要
  • 幹細胞研究
  • がん研究
  • 創薬研究
  • 再生医療

第7章 世界の3D細胞培養市場：エンドユーザー別

  • 概要
  • 学術機関
  • 受託研究ラボ・診断センター
  • バイオテクノロジーおよび製薬会社

第8章 3D細胞培養の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他中東とアフリカ

第9章 世界の3D細胞培養市場：競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な開発戦略
  • 企業の業界フットプリント
  • 企業の地域別フットプリント
  • エースマトリックス

第10章 企業プロファイル

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza Group Ltd.
  • Corning Incorporated
  • Sartorius AG
  • Becton, Dickinson and Company
  • 3D Biotek LLC
  • PromoCell GmbH
  • InSphero AG
  • Nanofiber Solutions LLC

第11章 主な発展

  • 製品の上市／開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

    • 関連調査
目次
Product Code: 6989

3D Cell Culture Market Size And Forecast

3D Cell Culture Market size was valued at USD 1.88 Billion in 2022 and is projected to reach USD 4.30 Billion in 2030 , at a CAGR of 10.87% from 2023 to 2030. Technological advancements in this segment, a growing emphasis on developing alternatives to animal testing, rising incidences of chronic diseases, and new product launches are expected to drive the 3D Cell Culture Market over the forecast years. The Global 3D Cell Culture Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global 3D Cell Culture Market Definition

3D cell culture is an artificially-created environment. A three-dimensional cell culture environment allows biological cells to interact with their surroundings in all three dimensions. In terms of cellular characteristics and behavior, cells grown in 3D cell culture exhibit similar properties to cells found in living organisms. In an in vivo condition, this technique allows cells to grow in their natural environment. In contrast to 2D environments, 3D cell culture enables cells to grow in all directions in an artificially created environment.

Biological cells are free to grow and interact with their surroundings in all three dimensions in this environment. Bioreactors and small capsules are frequently used to grow these three-dimensional environments in which cells can grow. 3D cell culture differentiates and migrates from normal cells by reacting to their three-dimensional surroundings. The enhanced utility of the cell aids in tissue maturation and organization. This method is commonly used in pharmaceutical and biotechnology companies, as well as academic institutions and research labs.

3D cultures are commonly used during research that requires in vivo model systems to study the effects of a foreign substance on bodily tissues and organs because they can precisely recreate the normal morphology and microarchitecture of organs. Moreover, due to the biomimetic tissue constructions used to produce 3D organotypic structures, a substantial number of research entities adopted 3-dimensional cell culture techniques. Furthermore, a novel approach to conventional methods for treating Covid-19, cancer, and other clinical illnesses has emerged: the use of 3D tissue-engineered models.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global 3D Cell Culture Market Overview

Rising public awareness of oncological diseases such as lung cancer and skin cancer, as well as the appealing benefits of 3D cell culture such as high strength and low prices, are among the factors expected to propel the expansion of the 3D Cell Culture Market. Moreover, its rising use in drug development and active government financial support for cancer research and advanced technologies as well as new product launches are anticipated to propel the 3D Cell Culture Market. In addition, the growing emphasis on developing alternatives to animal testing and growing market awareness is anticipated to drive the market. The availability of funding for research as well as the increasing incidence of chronic illnesses is predicted to fuel the market growth during the forecast years.

Furthermore, R&D efforts for drug discovery, innovation, and screening, as well as a preference for the use of 3D Cell culture in cancer research, are expected to propel market growth. Similarly, an increase in demand for organ transplantation is projected to augment the 3D Cell Culture Market growth. Cells grown on low-growth-factor scaffolds cannot be implanted in humans. This emphasises the need for materials that provide both natural ECM functionality and the ability to specify biological and material properties. Scaffolds made of synthetic materials, including such synthetic peptides, are anticipated to address this hindrance, however, lack of consistency continues to be a significant market problem until their initiation.

Moreover, excessive technology costs and a scarcity of skilled professionals are also anticipated to hamper market growth. Furthermore, Due to the COVID-19 pandemic, 3D cell culture is facing serious new difficulties in balancing the demand and availability of 3D cell culture components. Increasing inventions such as advanced treatments and diagnoses in neuromuscular disease are anticipated to provide abundant growth opportunities for the global 3D Cell Culture Market during the analysis timeframe. Moreover, advancements in 3D cell culture for replicating the entire spinal locomotion circuit are expected to grow the market. The rise in scientific research for developing novel therapies against COVID-19 represents a significant opportunity for market growth.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global 3D Cell Culture Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter's Five Forces

The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global 3D Cell Culture Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Global 3D Cell Culture Market Segmentation Analysis

The Global 3D Cell Culture Market is segmented on the basis of Type, Application, End Users, And Geography.

3D Cell Culture Market, By Type

3D Bioreactors

  • Scaffold-Based Platform
  • Scaffold-Free Platform
  • Other
  • To Get Summarized Market Report By Type:-

Based on Type, the market is segmented into 3D Bioreactors, Scaffold-Based Platform, Scaffold-Free Platform, and Other. 3D Bioreactors accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 20.03% during the forecast period. The bioreactor is composed of many independent, autoclavable polycarbonate chambers. The chambers are interchangeable and have been particularly designed to take advantage of 3D Insert scaffolds in sizes ranging from 24-well to 12-well to 6-well. Cell culture media is perfused through the open porous structure of scaffolds using a peristaltic pump. The entire unit is autoclavable and can be utilized as a single-use bioreactor system. Scaffold-based 3D Cell Cultures was the second-largest market in 2021, projected to grow at the highest CAGR of 18.88%.

  • The rising popularity and awareness of nanotechnology in biomedical research are expected to generate potential growth opportunities for nanofiber-based scaffolds, thereby increasing demand and sales for scaffold-based technology. Magnetic levitational assembly of 3D tissue constructs is a new and rapidly expanding label-free approach to tissue engineering. This is anticipated to propel the scaffold-free segment throughout the projected period.

3D Cell Culture Market, By Application

  • Stem Cell Research
  • Cancer Research
  • Drug Discovery
  • Regenerative Medicine

Based on Application, the market is segmented into Stem Cell Research, Cancer Research, Drug Discovery, and Regenerative Medicine. Stem cell research accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 19.40% during the forecast period. Merck is driven to develop novel cell culture systems and characterization tools for stem cell research and primary cell culture. Merck provides a complete line of stem cell products, such as human and murine stem cells, stem cell and primary cell culture media, growth factors, exclusive antibodies, culture ware, and kits. Cancer Research was the second-largest market in 2021, projected to grow at the highest CAGR of 18.90%.

  • It is mainly attributed to the advantages provided by 3D cell culture in cancer research, including the ease of changing cell proliferation and morphology, revealing realistic drug response, capturing phenotypic heterogeneity, enabling experimental manipulation in gene expression and cell behavior, and expressing the tumor microenvironment. Preclinical studies that use the benefits of 3D cell culture can significantly improve awareness of cancer biology. This includes the elimination of ineffective drug candidates as well as the identification of physiologically relevant targets that were previously inaccessible in 2D culture. This can significantly contribute to the segment's growth.

3D Cell Culture Market, By End Users

  • Academic Institutes
  • Contract Research Laboratories & Diagnostics Centers
  • Biotechnology and Pharmaceutical Companies

Based on End Users, the market is segmented into Academic Institutes, Contract Research Laboratories & Diagnostics Centers, and Biotechnology and Pharmaceutical Companies. Contract Research Laboratories & Diagnostics Center accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 19.24% during the forecast period. These contract research laboratories assist the primary R&D activities, by minimizing the time and resources required to complete the research project.

3D cell culture is the fastest growing segment in the healthcare space due to a wide range of applications in cancer research, in vitro environment, and regenerative medicine. The rise in the adoption of 3D cell culture in diagnostic centers and an increase in demand for organ transplantation and tissue regeneration leads to an increase in the growth of the segment. Biotechnology & Pharmaceutical Companies was the second-largest market in 2021, projected to grow at the highest CAGR of 18.76%.

  • In contrast to 2D cell culture, 3D cell culture has a wide range of benefits and advantages in terms of providing appropriate oxygen content and nutritional gradients, as well as aiding in the understanding of various cell functions such as adhesion, proliferation, morphology, viability, microenvironment, and drug response. These are some of the major factors driving the segment's development. The factors include a rising preference for alternative testing models over animal techniques, increased R&D spending in these companies, and the presence of a significant number of pharmaceutical and biotechnology firms.

3D Cell Culture Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America
  • To Get Summarized Market Report By Geography:-

Based on Geography, the Global 3D Cell Culture Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Middle East and Africa accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 22.66% during the forecast period. The steadily growing pharmaceutical industry and rising chronic diseases in the region are factors that lead to the increasing adoption of 3D cell culture, as cell culture is a vital function for drug discovery and cancer research which, in turn, helps to push the market growth over the forecast period.

  • Asia Pacific was the second-largest market in 2021, projected to grow at the highest CAGR of 20.65%. Cell culture is a crucial and mandatory function for drug discovery, cancer research, and stem cell research. Presently, most of the cells are cultured in 2D, where cells are grown as a single monolayer, instead in 3D cells grow in vivo. Hence growing cancer incidences and expanding pharmaceutical industry are likely to contribute to the growth of the 3D Cell Culture Market in the region.

Key Players

  • The "Global 3D Cell Culture Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market include
  • Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Corning Incorporated, Sartorius AG, Becton, Dickinson and Company, 3D Biotek LLC, PromoCell GmbH, InSphero AG, Nanofiber Solutions LLC, Synthecon, Inc., Global Cell Solutions, Inc., ReproCELL Inc., QGel SA, Greiner Bio-One International GmbH among others.

Our market analysis offers detailed information on major players wherein our analysts provide insight into the financial statements of all the major players, product portfolio, product benchmarking, and SWOT analysis. The competitive landscape section also includes market share analysis, key development strategies, recent developments, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In August 2021, Amerigo Scientific expanded its cell culture portfolio with the introduction of 3D Cell Culture for scientific applications. This new 3D cell culture system has applications in drug discovery, medicine, nanomaterial evaluation, and basic life science research.
  • In January 2021, Jellagen Limited, a biotechnology firm that produces high-value Collagen Type 0 derived from jellyfish, announced the release of its JellaGel Hydrogel, a 3D hydrogel. JellaGel offers customers hydrogel that is non-mammalian, natural, biochemically simple, consistent, and simple to use.
  • Ace Matrix Analysis:
  • The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
  • Active, Cutting Edge, Emerging, and Innovators.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL 3D CELL CULTURE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 EXECUTIVE SUMMARY

  • 2.1 Ecology mapping
  • 2.2 Market Attractiveness Analysis
  • 2.3 Absolute Market Opportunity
  • 2.4 Geographical Insights
  • 2.5 Future Market Opportunities
  • 2.6 Global Market Split

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Secondary Research
  • 3.3 Primary Research
  • 3.4 Subject Matter Expert Advice
  • 3.5 Quality Check
  • 3.6 Final Review
  • 3.7 Data Triangulation
  • 3.8 Bottom-Up Approach
  • 3.9 Top-Down Approach
  • 3.10 Research Flow
  • 3.11 Data Sources

4 GLOBAL 3D CELL CULTURE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Evolution
  • 4.3 Market Dynamics
    • 4.3.1 Drivers
    • 4.3.2 Restraints
    • 4.3.3 Opportunities
  • 4.4 Porters Five Force Model
  • 4.5 Value Chain Analysis
  • 4.6 Pricing Analysis

5 GLOBAL 3D CELL CULTURE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 3D Bioreactors
  • 5.3 Scaffold-Based Platform
  • 5.4 Scaffold-Free Platform
  • 5.5 Other

6 GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Stem Cell Research
  • 6.3 Cancer Research
  • 6.4 Drug Discovery
  • 6.5 Regenerative Medicine

7 GLOBAL 3D CELL CULTURE MARKET, BY END USERS

  • 7.1 Overview
  • 7.2 Academic Institutes
  • 7.3 Contract Research Laboratories & Diagnostics Centers
  • 7.4 Biotechnology and Pharmaceutical Companies

8 GLOBAL 3D CELL CULTURE MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 South Africa
    • 8.6.4 Rest of Middle East and Africa

9 GLOBAL 3D CELL CULTURE MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies
  • 9.4 Company Industry Footprint
  • 9.5 Company Regional Footprint
  • 9.6 Ace Matrix

10 COMPANY PROFILES

  • 10.1 Thermo Fisher Scientific Inc.
    • 10.1.1 Overview
    • 10.1.2 Company Insights
    • 10.1.3 Business Breakdown
    • 10.1.4 Product Outlook
    • 10.1.5 Key Developments
    • 10.1.6 Winning Imperatives
    • 10.1.7 Current Focus and Strategies
    • 10.1.8 Threat from Competition
    • 10.1.9 Swot Analysis
  • 10.2 Merck KGaA
    • 10.2.1 Overview
    • 10.2.2 Company Insights
    • 10.2.3 Business Breakdown
    • 10.2.4 Product Outlook
    • 10.2.5 Key Developments
    • 10.2.6 Winning Imperatives
    • 10.2.7 Current Focus and Strategies
    • 10.2.8 Threat from Competition
    • 10.2.9 Swot Analysis
  • 10.3 Lonza Group Ltd.
    • 10.3.1 Overview
    • 10.3.2 Company Insights
    • 10.3.3 Business Breakdown
    • 10.3.4 Product Outlook
    • 10.3.5 Key Developments
    • 10.3.6 Winning Imperatives
    • 10.3.7 Current Focus and Strategies
    • 10.3.8 Threat from Competition
    • 10.3.9 Swot Analysis
  • 10.4 Corning Incorporated
    • 10.4.1 Overview
    • 10.4.2 Company Insights
    • 10.4.3 Business Breakdown
    • 10.4.4 Product Outlook
    • 10.4.5 Key Developments
    • 10.4.6 Winning Imperatives
    • 10.4.7 Current Focus and Strategies
    • 10.4.8 Threat from Competition
    • 10.4.9 Swot Analysis
  • 10.5 Sartorius AG
    • 10.5.1 Overview
    • 10.5.2 Company Insights
    • 10.5.3 Business Breakdown
    • 10.5.4 Product Outlook
    • 10.5.5 Key Developments
    • 10.5.6 Winning Imperatives
    • 10.5.7 Current Focus and Strategies
    • 10.5.8 Threat from Competition
    • 10.5.9 Swot Analysis
  • 10.6 Becton, Dickinson and Company
    • 10.6.1 Overview
    • 10.6.2 Company Insights
    • 10.6.3 Business Breakdown
    • 10.6.4 Product Outlook
    • 10.6.5 Key Developments
    • 10.6.6 Winning Imperatives
    • 10.6.7 Current Focus and Strategies
    • 10.6.8 Threat from Competition
    • 10.6.9 Swot Analysis
  • 10.7 3D Biotek LLC
    • 10.7.1 Overview
    • 10.7.2 Company Insights
    • 10.7.3 Business Breakdown
    • 10.7.4 Product Outlook
    • 10.7.5 Key Developments
    • 10.7.6 Winning Imperatives
    • 10.7.7 Current Focus and Strategies
    • 10.7.8 Threat from Competition
    • 10.7.9 Swot Analysis
  • 10.8 PromoCell GmbH
    • 10.8.1 Overview
    • 10.8.2 Company Insights
    • 10.8.3 Business Breakdown
    • 10.8.4 Product Outlook
    • 10.8.5 Key Developments
    • 10.8.6 Winning Imperatives
    • 10.8.7 Current Focus and Strategies
    • 10.8.8 Threat from Competition
    • 10.8.9 Swot Analysis
  • 10.9 InSphero AG
    • 10.9.1 Overview
    • 10.9.2 Company Insights
    • 10.9.3 Business Breakdown
    • 10.9.4 Product Outlook
    • 10.9.5 Key Developments
    • 10.9.6 Winning Imperatives
    • 10.9.7 Current Focus and Strategies
    • 10.9.8 Threat from Competition
    • 10.9.9 Swot Analysis
  • 10.10 Nanofiber Solutions LLC
    • 10.10.1 Overview
    • 10.10.2 Company Insights
    • 10.10.3 Business Breakdown
    • 10.10.4 Product Outlook
    • 10.10.5 Key Developments
    • 10.10.6 Winning Imperatives
    • 10.10.7 Current Focus and Strategies
    • 10.10.8 Threat from Competition
    • 10.10.9 Swot Analysis

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

    • 12.1.1 Related Research